date:Jan 08, 2014
hromaDex's recently launched patented NIAGEN Nicotinamide Riboside (NR) for use in dietary supplements exclusively in the network marketing sales channel in the United States, Canada and Philippines. Under the terms of the agreement, 5LINX must purchase from ChromaDex $2.1 million of NIAGEN in 2014, and an aggregate of $46 million of NIAGEN from 2015 through 2017. NIAGEN is the first and only commercially available brand of NR, which is found naturally in trace amounts in milk and other foods